Global Novel Drug Delivery Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 143603
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.

Scope of the Report:

The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017.

North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.

The worldwide market for Novel Drug Delivery Systems is expected to grow at a CAGR of roughly 2.2% over the next five years, will reach 30300 million US$ in 2024, from 26500 million US$ in 2019, according to a new study.

This report focuses on the Novel Drug Delivery Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Amgen

Teva

UCB (Union Chimique Belge)

Roche

Celgene

Sanofi

Merck

Johnson & Johnson

Takeda

Gilead Sciences

Pfizer

Dr Reddy

Samyang Biopharmaceuticals

TOLMAR

Astellas

AMAG Pharmaceuticals

AstraZeneca

AbbVie

Bausch&Lomb

TWi Pharmaceuticals

Novartis

Aspen

Shire

Breckenridge Pharmaceuticals

Galen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Liposomes

PEGylated Proteins & Polypeptides

Polymer Nanoparticle

Protein–drug Conjugates

Others

Market Segment by Applications, can be divided into

Hospitals & Clinic

Cancer Treatment Centers

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Novel Drug Delivery Systems product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Novel Drug Delivery Systems, with price, sales, revenue and global market share of Novel Drug Delivery Systems in 2017 and 2018.

Chapter 3, the Novel Drug Delivery Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Novel Drug Delivery Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Novel Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Novel Drug Delivery Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Novel Drug Delivery Systems Introduction

1.2 Market Analysis by Type

1.2.1 Liposomes

1.2.2 PEGylated Proteins & Polypeptides

1.2.3 Polymer Nanoparticle

1.2.4 Protein–drug Conjugates

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals & Clinic

1.3.2 Cancer Treatment Centers

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Novel Drug Delivery Systems Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Teva

2.2.1 Business Overview

2.2.2 Novel Drug Delivery Systems Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Teva Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 UCB (Union Chimique Belge)

2.3.1 Business Overview

2.3.2 Novel Drug Delivery Systems Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Roche

2.4.1 Business Overview

2.4.2 Novel Drug Delivery Systems Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Roche Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Celgene

2.5.1 Business Overview

2.5.2 Novel Drug Delivery Systems Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Celgene Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Sanofi

2.6.1 Business Overview

2.6.2 Novel Drug Delivery Systems Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sanofi Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Merck

2.7.1 Business Overview

2.7.2 Novel Drug Delivery Systems Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Johnson & Johnson

2.8.1 Business Overview

2.8.2 Novel Drug Delivery Systems Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Takeda

2.9.1 Business Overview

2.9.2 Novel Drug Delivery Systems Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Takeda Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Gilead Sciences

2.10.1 Business Overview

2.10.2 Novel Drug Delivery Systems Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Gilead Sciences Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Pfizer

2.11.1 Business Overview

2.11.2 Novel Drug Delivery Systems Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Pfizer Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.12 Dr Reddy

2.12.1 Business Overview

2.12.2 Novel Drug Delivery Systems Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Dr Reddy Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.13 Samyang Biopharmaceuticals

2.13.1 Business Overview

2.13.2 Novel Drug Delivery Systems Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.14 TOLMAR

2.14.1 Business Overview

2.14.2 Novel Drug Delivery Systems Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 TOLMAR Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.15 Astellas

2.15.1 Business Overview

2.15.2 Novel Drug Delivery Systems Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Astellas Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.16 AMAG Pharmaceuticals

2.16.1 Business Overview

2.16.2 Novel Drug Delivery Systems Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.17 AstraZeneca

2.17.1 Business Overview

2.17.2 Novel Drug Delivery Systems Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 AstraZeneca Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.18 AbbVie

2.18.1 Business Overview

2.18.2 Novel Drug Delivery Systems Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 AbbVie Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.19 Bausch&Lomb

2.19.1 Business Overview

2.19.2 Novel Drug Delivery Systems Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Bausch&Lomb Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.20 TWi Pharmaceuticals

2.20.1 Business Overview

2.20.2 Novel Drug Delivery Systems Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 TWi Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.21 Novartis

2.21.1 Business Overview

2.2.2 Novel Drug Delivery Systems Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Novartis Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.22 Aspen

2.22.1 Business Overview

2.22.2 Novel Drug Delivery Systems Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 Aspen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.23 Shire

2.23.1 Business Overview

2.23.2 Novel Drug Delivery Systems Type and Applications

2.23.2.1 Product A

2.23.2.2 Product B

2.23.3 Shire Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.24 Breckenridge Pharmaceuticals

2.24.1 Business Overview

2.24.2 Novel Drug Delivery Systems Type and Applications

2.24.2.1 Product A

2.24.2.2 Product B

2.24.3 Breckenridge Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.25 Galen

2.25.1 Business Overview

2.25.2 Novel Drug Delivery Systems Type and Applications

2.25.2.1 Product A

2.25.2.2 Product B

2.25.3 Galen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Novel Drug Delivery Systems Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Novel Drug Delivery Systems Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Novel Drug Delivery Systems Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Novel Drug Delivery Systems Manufacturer Market Share in 2018

3.3.2 Top 6 Novel Drug Delivery Systems Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Novel Drug Delivery Systems Market Analysis by Regions

4.1 Global Novel Drug Delivery Systems Sales, Revenue and Market Share by Regions

4.1.1 Global Novel Drug Delivery Systems Sales and Market Share by Regions (2014-2019)

4.1.2 Global Novel Drug Delivery Systems Revenue and Market Share by Regions (2014-2019)

4.2 North America Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

4.3 Europe Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

4.5 South America Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

5 North America Novel Drug Delivery Systems by Country

5.1 North America Novel Drug Delivery Systems Sales, Revenue and Market Share by Country

5.1.1 North America Novel Drug Delivery Systems Sales and Market Share by Country (2014-2019)

5.1.2 North America Novel Drug Delivery Systems Revenue and Market Share by Country (2014-2019)

5.2 United States Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

5.3 Canada Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

5.4 Mexico Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

6 Europe Novel Drug Delivery Systems by Country

6.1 Europe Novel Drug Delivery Systems Sales, Revenue and Market Share by Country

6.1.1 Europe Novel Drug Delivery Systems Sales and Market Share by Country (2014-2019)

6.1.2 Europe Novel Drug Delivery Systems Revenue and Market Share by Country (2014-2019)

6.2 Germany Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

6.3 UK Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

6.4 France Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

6.5 Russia Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

6.6 Italy Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

7 Asia-Pacific Novel Drug Delivery Systems by Country

7.1 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Novel Drug Delivery Systems Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Novel Drug Delivery Systems Revenue and Market Share by Country (2014-2019)

7.2 China Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

7.3 Japan Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

7.4 Korea Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

7.5 India Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

8 South America Novel Drug Delivery Systems by Country

8.1 South America Novel Drug Delivery Systems Sales, Revenue and Market Share by Country

8.1.1 South America Novel Drug Delivery Systems Sales and Market Share by Country (2014-2019)

8.1.2 South America Novel Drug Delivery Systems Revenue and Market Share by Country (2014-2019)

8.2 Brazil Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

8.3 Argentina Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

8.4 Colombia Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

9 Middle East and Africa Novel Drug Delivery Systems by Countries

9.1 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Novel Drug Delivery Systems Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Novel Drug Delivery Systems Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

9.3 Turkey Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

9.4 Egypt Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

9.5 Nigeria Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

9.6 South Africa Novel Drug Delivery Systems Sales and Growth Rate (2014-2019)

10 Global Novel Drug Delivery Systems Market Segment by Type

10.1 Global Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Novel Drug Delivery Systems Sales and Market Share by Type (2014-2019)

10.1.2 Global Novel Drug Delivery Systems Revenue and Market Share by Type (2014-2019)

10.2 Liposomes Sales Growth and Price

10.2.1 Global Liposomes Sales Growth (2014-2019)

10.2.2 Global Liposomes Price (2014-2019)

10.3 PEGylated Proteins & Polypeptides Sales Growth and Price

10.3.1 Global PEGylated Proteins & Polypeptides Sales Growth (2014-2019)

10.3.2 Global PEGylated Proteins & Polypeptides Price (2014-2019)

10.4 Polymer Nanoparticle Sales Growth and Price

10.4.1 Global Polymer Nanoparticle Sales Growth (2014-2019)

10.4.2 Global Polymer Nanoparticle Price (2014-2019)

10.5 Protein–drug Conjugates Sales Growth and Price

10.5.1 Global Protein–drug Conjugates Sales Growth (2014-2019)

10.5.2 Global Protein–drug Conjugates Price (2014-2019)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2014-2019)

10.6.2 Global Others Price (2014-2019)

11 Global Novel Drug Delivery Systems Market Segment by Application

11.1 Global Novel Drug Delivery Systems Sales Market Share by Application (2014-2019)

11.2 Hospitals & Clinic Sales Growth (2014-2019)

11.3 Cancer Treatment Centers Sales Growth (2014-2019)

11.4 Others Sales Growth (2014-2019)

12 Novel Drug Delivery Systems Market Forecast (2019-2024)

12.1 Global Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2019-2024)

12.2 Novel Drug Delivery Systems Market Forecast by Regions (2019-2024)

12.2.1 North America Novel Drug Delivery Systems Market Forecast (2019-2024)

12.2.2 Europe Novel Drug Delivery Systems Market Forecast (2019-2024)

12.2.3 Asia-Pacific Novel Drug Delivery Systems Market Forecast (2019-2024)

12.2.4 South America Novel Drug Delivery Systems Market Forecast (2019-2024)

12.2.5 Middle East and Africa Novel Drug Delivery Systems Market Forecast (2019-2024)

12.3 Novel Drug Delivery Systems Market Forecast by Type (2019-2024)

12.3.1 Global Novel Drug Delivery Systems Sales Forecast by Type (2019-2024)

12.3.2 Global Novel Drug Delivery Systems Market Share Forecast by Type (2019-2024)

12.4 Novel Drug Delivery Systems Market Forecast by Application (2019-2024)

12.4.1 Global Novel Drug Delivery Systems Sales Forecast by Application (2019-2024)

12.4.2 Global Novel Drug Delivery Systems Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Novel Drug Delivery Systems Picture

Table Product Specifications of Novel Drug Delivery Systems

Figure Global Sales Market Share of Novel Drug Delivery Systems by Ty

Please fill the form below, to recieve the report sample


+1